Please assess the completion status of the following clinical trial:

Trial Title: G-PUR® for Reduced Dietary Fumonisin Bioavailability

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy male and female subjects~2. Age 18-55 years~3. BMI 17-27~4. Subjects are in good clinical and mental health as established by medical history and physical examination~5. Subject understands the scope of the study and agrees to strictly adhere to the study related diet plan~6. Written informed consent~Exclusion Criteria:~1. Pregnancy or breastfeeding.~2. Lack of willingness or capacity to co-operate appropriately~3. Regular use of medications in the previous 2 months (except oral contraception)~4. History of malignancies within the past two years or on current anticancer treatment~5. History of gastrointestinal pathology such as clinically relevant gastritis, gastric ulcers, inflammatory bowel disease, chronic constipation~6. History of diarrhoea within the past 14 days of screening~7. History of gastrointestinal surgery with exception of appendectomy~8. History of any chronic liver disease~9. History of autoimmune disease requiring treatment within the past two months of screening~10. Known symptomatic food allergies~11. Active infection (including HIV and hepatitis B or C), or abnormalities in laboratory testing, vital signs, or physical examination~12. Hypersensitivity to aluminium and/or silicon~13. Chronic renal disease requiring dialysis~14. Alcohol, cigarette or drug abuse~15. Presence of any condition that impacts compliance with the study procedures~16. Use of any investigational or non-registered product (drug or device) within 30 days preceding the first study product administration, or planned use during the study period~17. Employee at the study site, spouse/partner or relative of any study staff (e.g. investigator, sub-investigators, or study nurse) or relationship to the sponsor

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 2.0g G-PUR® oral - Placebo (Type: EXPERIMENTAL): None
- Placebo - 2.0g G-PUR® oral (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).